Healthcare provider profile · identity verified

Mohammed Mudasser Khan, MD

Family Practice · BELVIDERE, IL · NPI 1679703797

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	827	215
Amlodipine Besylate	Amlodipine Besylate	474	134
Omeprazole	Omeprazole	436	133
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	431	68
Lisinopril	Lisinopril	423	114
Metformin Hcl	Metformin Hcl	406	118
Levothyroxine Sodium	Levothyroxine Sodium	389	103
Losartan Potassium	Losartan Potassium	340	97
Gabapentin	Gabapentin	302	82
Tamsulosin Hcl	Tamsulosin Hcl	296	87
Metoprolol Succinate	Metoprolol Succinate	293	79
Pravastatin Sodium	Pravastatin Sodium	272	72
Alprazolam	Alprazolam	262	42
Fluticasone Propionate	Fluticasone Propionate	259	106
Simvastatin	Simvastatin	242	67
Furosemide	Furosemide	235	81
Metoprolol Tartrate	Metoprolol Tartrate	222	66
Lorazepam	Lorazepam	221	39
Meloxicam	Meloxicam	209	81
Hydrochlorothiazide	Hydrochlorothiazide	200	57
Tramadol Hcl	Tramadol Hcl	186	37
Potassium Chloride	Potassium Chloride	177	54
Glimepiride	Glimepiride	173	49
Pantoprazole Sodium	Pantoprazole Sodium	173	51
Albuterol Sulfate Hfa	Albuterol Sulfate	160	72
Carvedilol	Carvedilol	143	42
Allopurinol	Allopurinol	129	36
Fenofibrate	Fenofibrate	128	40
Trazodone Hcl	Trazodone Hcl	121	32
Alendronate Sodium	Alendronate Sodium	114	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	35
Zolpidem Tartrate	Zolpidem Tartrate	108	21
Montelukast Sodium	Montelukast Sodium	107	31
Ozempic	Semaglutide	103	18
Sertraline Hcl	Sertraline Hcl	103	35
Rosuvastatin Calcium	Rosuvastatin Calcium	102	31
Prednisone	Prednisone	98	82
Spironolactone	Spironolactone	95	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	94	22
Diclofenac Sodium	Diclofenac Sodium	92	27
Eliquis	Apixaban	91	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	18
Tizanidine Hcl	Tizanidine Hcl	83	34
Atenolol	Atenolol	82	17
Glipizide	Glipizide	81	23
Xarelto	Rivaroxaban	80	20
Venlafaxine Hcl Er	Venlafaxine Hcl	78	20
Clonazepam	Clonazepam	74	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	74	23
Warfarin Sodium	Warfarin Sodium	74	19
Duloxetine Hcl	Duloxetine Hcl	73	17
Escitalopram Oxalate	Escitalopram Oxalate	70	22
Finasteride	Finasteride	69	21
Enalapril Maleate	Enalapril Maleate	68	19
Fluoxetine Hcl	Fluoxetine Hcl	68	20
Clopidogrel	Clopidogrel Bisulfate	67	20
Oxybutynin Chloride	Oxybutynin Chloride	63	17
Triamcinolone Acetonide	Triamcinolone Acetonide	60	36
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	57	39
Hydroxyzine Hcl	Hydroxyzine Hcl	56	14
Januvia	Sitagliptin Phosphate	56	14
Esomeprazole Magnesium	Esomeprazole Magnesium	53	12
Citalopram Hbr	Citalopram Hydrobromide	52	15
Quetiapine Fumarate	Quetiapine Fumarate	51	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	11
Hydralazine Hcl	Hydralazine Hcl	47	13
Jardiance	Empagliflozin	47	16
Ropinirole Hcl	Ropinirole Hcl	45	13
Azithromycin	Azithromycin	44	42
Pregabalin	Pregabalin	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	13
Acetaminophen-Codeine	Acetaminophen With Codeine	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	14
Glipizide Er	Glipizide	40	11
Famotidine	Famotidine	39	16
Fenofibrate	Fenofibrate Nanocrystallized	39	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	11
Lovastatin	Lovastatin	38	13
Synthroid	Levothyroxine Sodium	38	11
Ventolin Hfa	Albuterol Sulfate	38	18
Ondansetron Odt	Ondansetron	37	suppressed
Clonidine Hcl	Clonidine Hcl	36	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Flecainide Acetate	Flecainide Acetate	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Ramipril	Ramipril	34	suppressed
Bupropion Xl	Bupropion Hcl	33	12
Celecoxib	Celecoxib	33	15
Cephalexin	Cephalexin	33	29
Gemfibrozil	Gemfibrozil	33	11
Diazepam	Diazepam	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	25
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	11
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Propranolol Hcl Er	Propranolol Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	suppressed
Diltiazem Hcl	Diltiazem Hcl	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	12
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Topiramate	Topiramate	25	suppressed
Methadone Hcl	Methadone Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Calcitriol	Calcitriol	23	suppressed
Hydrocortisone	Hydrocortisone	23	12
Calcitonin-Salmon	Calcitonin,salmon,synthetic	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	12
Buspirone Hcl	Buspirone Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	19	suppressed
Nystatin	Nystatin	19	suppressed
Phenobarbital	Phenobarbital	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	19
Benazepril Hcl	Benazepril Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Temazepam	Temazepam	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Hydroxyurea	Hydroxyurea	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Embrace Pen Needle	Pen Needle, Diabetic	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Thioridazine Hcl	Thioridazine Hcl	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Digoxin	Digoxin	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error